Publicaciones en colaboración con investigadores/as de University of California, San Diego (13)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  2. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

    Cell Reports, Vol. 37, Núm. 7

2016

  1. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1710-1723

2015

  1. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance

    Diabetes, Vol. 64, Núm. 5, pp. 1522-1531

  2. Morphometric analysis of immunoselection against hyperploid cancer cells

    Oncotarget, Vol. 6, Núm. 38, pp. 41204-41215

  3. Regulation of microRNA 183 by cyclooxygenase 2 in liver is DEAD-box helicase p68 (DDX5) dependent: Role in insulin signaling

    Molecular and Cellular Biology, Vol. 35, Núm. 14, pp. 2554-2567

2011

  1. Protein kinase C η is required for T cell activationand homeostatic proliferation

    Science Signaling, Vol. 4, Núm. 202

2007

  1. Cutting edge: Selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase

    Journal of Immunology, Vol. 179, Núm. 6, pp. 3402-3406

2004

  1. Protein tyrosine phosphatases in the human genome

    Cell, Vol. 117, Núm. 6, pp. 699-711

2003

  1. Inhibition of IκB kinase by a new class of retinoid-related anticancer agents that induce apoptosis

    Molecular and Cellular Biology, Vol. 23, Núm. 3, pp. 1061-1074

1994

  1. Rapid heterologous desensitization of muscarinic and thrombin receptor- mediated phospholipase D activation

    Molecular Pharmacology, Vol. 46, Núm. 3, pp. 406-413